Washington Trust Advisors, Inc. Organon & Co. Transaction History

Washington Trust Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$23.31 - $28.61 $3,473 - $4,262	-149 Reduced 83.24%	30 $0
Q3 2022 Oct 14, 2022	BUY	$23.4 - $34.25 $23 - $34	1 Added 0.56%	179 $4,000
Q2 2022 Jul 25, 2022	SELL	$31.66 - $38.9 $10,416 - $12,798	-329 Reduced 64.89%	178 $6,000
Q1 2022 May 05, 2022	SELL	$30.45 - $39.36 $2,253 - $2,912	-74 Reduced 12.74%	507 $18,000
Q4 2021 Feb 11, 2022	BUY	$28.67 - $37.13 $16,657 - $21,572	581 New	581 $18,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Washington Trust Advisors, Inc. with notifications on news.